1. Home
  2. SDGR vs RPD Comparison

SDGR vs RPD Comparison

Compare SDGR & RPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDGR
  • RPD
  • Stock Information
  • Founded
  • SDGR 1990
  • RPD 2000
  • Country
  • SDGR United States
  • RPD United States
  • Employees
  • SDGR N/A
  • RPD N/A
  • Industry
  • SDGR Biotechnology: Pharmaceutical Preparations
  • RPD Computer Software: Prepackaged Software
  • Sector
  • SDGR Health Care
  • RPD Technology
  • Exchange
  • SDGR Nasdaq
  • RPD Nasdaq
  • Market Cap
  • SDGR 1.4B
  • RPD 1.3B
  • IPO Year
  • SDGR 2020
  • RPD 2015
  • Fundamental
  • Price
  • SDGR $18.51
  • RPD $19.65
  • Analyst Decision
  • SDGR Buy
  • RPD Hold
  • Analyst Count
  • SDGR 7
  • RPD 19
  • Target Price
  • SDGR $28.43
  • RPD $27.00
  • AVG Volume (30 Days)
  • SDGR 1.2M
  • RPD 746.5K
  • Earning Date
  • SDGR 11-11-2025
  • RPD 11-05-2025
  • Dividend Yield
  • SDGR N/A
  • RPD N/A
  • EPS Growth
  • SDGR N/A
  • RPD N/A
  • EPS
  • SDGR N/A
  • RPD 0.43
  • Revenue
  • SDGR $237,917,000.00
  • RPD $855,361,000.00
  • Revenue This Year
  • SDGR $23.71
  • RPD $2.75
  • Revenue Next Year
  • SDGR $21.80
  • RPD $3.32
  • P/E Ratio
  • SDGR N/A
  • RPD $46.50
  • Revenue Growth
  • SDGR 18.59
  • RPD 4.67
  • 52 Week Low
  • SDGR $16.60
  • RPD $17.83
  • 52 Week High
  • SDGR $28.47
  • RPD $44.48
  • Technical
  • Relative Strength Index (RSI)
  • SDGR 40.66
  • RPD 43.24
  • Support Level
  • SDGR $18.13
  • RPD $19.36
  • Resistance Level
  • SDGR $19.71
  • RPD $21.26
  • Average True Range (ATR)
  • SDGR 0.67
  • RPD 0.62
  • MACD
  • SDGR -0.04
  • RPD 0.00
  • Stochastic Oscillator
  • SDGR 17.18
  • RPD 18.42

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

About RPD Rapid7 Inc.

Founded in 2000, Rapid7 is a cybersecurity company that began providing vulnerability management solutions. It has, however, expanded its portfolio to provide extended detection and response; security information and event management; cloud security, threat intelligence, and application security; and security orchestration, automation, and response. The Boston-based company went public in 2015.

Share on Social Networks: